GALC and myeloid sarcoma: Galactocerebrosidase (GALC), which has been identified as a risk factor for MS, also participates in microglia phagocytic clearance of myelin debris, with GALC ablated mice showing reduced remyelination (Scott-Hewitt et al., 2017).